Azur Pharma is a private company headquartered in Dublin, Ireland. Azur Pharma was founded in mid 2005. Since its inception Azur Pharma has raised €75 million ($110 million) of equity.
In June 2005, Azur Pharma successfully completed a private placement of equity securities in an amount of €40 million ($60 million).
In August 2007, Azur Pharma successfully completed a private placement of ordinary shares for €35 million ($50 million). The new share issuance represented 28% of Azur's outstanding share capital.
For further investor information please contact David Brabazon, Chief Financial Officer, at +353 1 634 4180.